The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...

Webinar Information

Webinar Description

Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.

Learning Objectives

  • Describe the mechanisms by which the ketogenic diet may have anticancer activity.
  • Discuss the design and results of a phase 1 safety and feasibility trial of a ketogenic diet plus standard care for patients with recently diagnosed glioblastoma.
  • Recognize the challenges of implementing and studying a ketogenic diet for patients and research scientists.
  • Describe the basic pathophysiology and standard treatment for primary brain tumors.

 

Webinar Documents

Handouts

 

Webinar Registration


Take Course

You must have an account and be logged in to register. Please contact us with any questions at unclcn@unc.edu or (919) 445–1000.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
07/03/2023
Course expires: 
07/02/2024
Rating: 
5
Photo of Jethro L. Hu, MD 

Jethro L. Hu, MD

Associate Professor, Departments of Medicine, Neurology, and Neurosurgery
Cedars-Sinai Medical Center

 

Presenter Disclosure Information

The presenter has no relevant financial relationships with ineligible companies as defined by the ACCME.

Requirements for Receiving Free Continuing Education Credits

  • Watch the video
  • Complete the assessment with a score of 80% or better
  • Complete the evaluation
  • Download the appropriate certificate

Please see our detailed instructions for more information on completing the Self-Paced, Online Courses and receiving credit.


Accreditation Statements

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency. No partial credit will be provided.

1.00 NCPD/CNE
The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

1.00 CTR
Approved by the National Cancer Registrars Association (NCRA).

1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).


In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to view a minimum of 50 minutes of the live webinar video to receive CE credit. Please contact your individual accreditation agencies for more details.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.